Lumentum (LITE) CFO sells 5,302 shares in Rule 10b5-1 stock plan

Q: How many Lumentum (LITE) shares did the CFO sell in this Form 4?

Lumentum’s CFO Ali Wajid sold 5,302 shares of common stock. The sales occurred through multiple open-market transactions, all on February 27, 2026, as disclosed in the Form 4 transaction summary.

Q: At what prices did Lumentum (LITE) CFO Ali Wajid sell his shares?

The reported sales were executed at prices between $677.705 and $699.495 per share. Individual trades occurred within narrower ranges, with each line item showing a weighted average sale price for that group of transactions.

Q: Were the Lumentum (LITE) CFO’s stock sales part of a 10b5-1 trading plan?

Yes. The filing states these shares were sold under a Rule 10b5-1 trading plan adopted by Ali Wajid on November 28, 2025, indicating the transactions were pre-arranged rather than discretionary.

Q: What type of transactions are reported for Lumentum (LITE) CFO in this Form 4?

All reported transactions are open-market sales of common stock coded as “S.” The Form 4 describes them as sales in open market or private transactions, but each entry lists them as non-derivative common stock sales.

Q: Did Lumentum (LITE) CFO buy any shares in this Form 4 filing?

No. The transaction summary shows 13 sale transactions totaling 5,302 shares and no purchases or acquisitions. Net activity for the period is therefore entirely on the selling side.

Filing Impact

(Very High)

Filing Sentiment

(Negative)

Form Type

Rhea-AI Filing Summary

Lumentum Holdings Inc. executive vice president and chief financial officer Ali Wajid reported open-market sales of 5,302 shares of common stock on February 27, 2026. The trades were executed in multiple transactions at prices ranging from about $677.705 to $699.495 per share, under a pre-arranged Rule 10b5-1 trading plan adopted on November 28, 2025. Following these sales, Wajid directly owned 66,287 shares of Lumentum common stock.

Insider Trade Summary

Net Seller: 5,302 shares ($3,664,387)

Net Sell 13 txns

Insider Ali Wajid

Role EVP & CHIEF FINANCIAL OFFICER

Sold 5,302 shs ($3.66M)

Type	Security	Shares	Price	Value
Sale	Common Stock	200	$677.7775	$136K
Sale	Common Stock	424	$679.95	$288K
Sale	Common Stock	500	$681.481	$341K
Sale	Common Stock	200	$685.495	$137K
Sale	Common Stock	160	$686.5438	$110K
Sale	Common Stock	475	$688.4164	$327K
Sale	Common Stock	155	$690.1261	$107K
Sale	Common Stock	731	$692.0239	$506K
Sale	Common Stock	450	$694.7644	$313K
Sale	Common Stock	355	$696.117	$247K
Sale	Common Stock	300	$697.0833	$209K
Sale	Common Stock	1,108	$698.0997	$773K
Sale	Common Stock	244	$699.2798	$171K

Holdings After Transaction: Common Stock — 71,389 shares (Direct)

Footnotes (1)

These shares were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 28, 2025. These sales were executed in multiple trades at prices ranging from $677.705 to $677.85. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide full information regarding the number of shares sold at each separate price, within the ranges set forth in footnotes (2) through (13) to this Form 4, upon request, to the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer. These sales were executed in multiple trades at prices ranging from $680.99 to $681.805. These sales were executed in multiple trades at prices ranging from $685.26 to $685.73. These sales were executed in multiple trades at prices ranging from $686.54 to $686.55. These sales were executed in multiple trades at prices ranging from $688.07 to $688.85. These sales were executed in multiple trades at prices ranging from $690.01 to $690.31. These sales were executed in multiple trades at prices ranging from $692.00 to $692.855. These sales were executed in multiple trades at prices ranging from $694.255 to $694.99. These sales were executed in multiple trades at prices ranging from $695.75 to $696.65. These sales were executed in multiple trades at prices ranging from $696.875 to $697.50. These sales were executed in multiple trades at prices ranging from $698.00 to $698.50. These sales were executed in multiple trades at prices ranging from $699.00 to $699.495.

Form 4 Insider Transactions: What Each Field Means →

03/02/2026 - 05:28 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Ali Wajid

(Last)

(First)

(Middle)

C/O LUMENTUM HOLDINGS INC.

1001 RIDDER PARK DRIVE

(Street)

SAN JOSE

95131

(City)

(State)

(Zip)

2. Issuer Name and Ticker or Trading Symbol
Lumentum Holdings Inc. [ LITE ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	EVP & CHIEF FINANCIAL OFFICER

3. Date of Earliest Transaction (Month/Day/Year)
02/27/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	02/27/2026		S⁽¹⁾		200	D	$677.7775⁽²⁾	71,389	D
Common Stock	02/27/2026		S⁽¹⁾		424	D	$679.95	70,965	D
Common Stock	02/27/2026		S⁽¹⁾		500	D	$681.481⁽³⁾	70,465	D
Common Stock	02/27/2026		S⁽¹⁾		200	D	$685.495⁽⁴⁾	70,265	D
Common Stock	02/27/2026		S⁽¹⁾		160	D	$686.5438⁽⁵⁾	70,105	D
Common Stock	02/27/2026		S⁽¹⁾		475	D	$688.4164⁽⁶⁾	69,630	D
Common Stock	02/27/2026		S⁽¹⁾		155	D	$690.1261⁽⁷⁾	69,475	D
Common Stock	02/27/2026		S⁽¹⁾		731	D	$692.0239⁽⁸⁾	68,744	D
Common Stock	02/27/2026		S⁽¹⁾		450	D	$694.7644⁽⁹⁾	68,294	D
Common Stock	02/27/2026		S⁽¹⁾		355	D	$696.117⁽¹⁰⁾	67,939	D
Common Stock	02/27/2026		S⁽¹⁾		300	D	$697.0833⁽¹¹⁾	67,639	D
Common Stock	02/27/2026		S⁽¹⁾		1,108	D	$698.0997⁽¹²⁾	66,531	D
Common Stock	02/27/2026		S⁽¹⁾		244	D	$699.2798⁽¹³⁾	66,287	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

1. These shares were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 28, 2025.

2. These sales were executed in multiple trades at prices ranging from $677.705 to $677.85. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide full information regarding the number of shares sold at each separate price, within the ranges set forth in footnotes (2) through (13) to this Form 4, upon request, to the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer.

3. These sales were executed in multiple trades at prices ranging from $680.99 to $681.805.

4. These sales were executed in multiple trades at prices ranging from $685.26 to $685.73.

5. These sales were executed in multiple trades at prices ranging from $686.54 to $686.55.

6. These sales were executed in multiple trades at prices ranging from $688.07 to $688.85.

7. These sales were executed in multiple trades at prices ranging from $690.01 to $690.31.

8. These sales were executed in multiple trades at prices ranging from $692.00 to $692.855.

9. These sales were executed in multiple trades at prices ranging from $694.255 to $694.99.

10. These sales were executed in multiple trades at prices ranging from $695.75 to $696.65.

11. These sales were executed in multiple trades at prices ranging from $696.875 to $697.50.

12. These sales were executed in multiple trades at prices ranging from $698.00 to $698.50.

13. These sales were executed in multiple trades at prices ranging from $699.00 to $699.495.

	/s/ Jae Kim as Attorney-in-Fact	03/02/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source: View Original Filing on SEC EDGAR

FAQ

How many Lumentum (LITE) shares did the CFO sell in this Form 4?

Lumentum’s CFO Ali Wajid sold 5,302 shares of common stock. The sales occurred through multiple open-market transactions, all on February 27, 2026, as disclosed in the Form 4 transaction summary.

At what prices did Lumentum (LITE) CFO Ali Wajid sell his shares?

The reported sales were executed at prices between $677.705 and $699.495 per share. Individual trades occurred within narrower ranges, with each line item showing a weighted average sale price for that group of transactions.

How many Lumentum (LITE) shares does the CFO hold after these transactions?

After the reported open-market sales, Ali Wajid directly owned 66,287 Lumentum common shares. This post-transaction balance is shown in the final line of the Form 4 transaction table for his holdings.

Were the Lumentum (LITE) CFO’s stock sales part of a 10b5-1 trading plan?

Yes. The filing states these shares were sold under a Rule 10b5-1 trading plan adopted by Ali Wajid on November 28, 2025, indicating the transactions were pre-arranged rather than discretionary.

What type of transactions are reported for Lumentum (LITE) CFO in this Form 4?

All reported transactions are open-market sales of common stock coded as “S.” The Form 4 describes them as sales in open market or private transactions, but each entry lists them as non-derivative common stock sales.

Did Lumentum (LITE) CFO buy any shares in this Form 4 filing?

No. The transaction summary shows 13 sale transactions totaling 5,302 shares and no purchases or acquisitions. Net activity for the period is therefore entirely on the selling side.